Back to results
US 2017/0246254 A1Published application
Lyophilised pharmaceutical formulation and its use
AssigneeFaron Pharmaceuticals Oy
InventorsMarkku JALKANEN, Mikael MAKSIMOW, Ilse Piippo
Life of this patent
Estimating the term…
Abstract
A pharmaceutical formulation in a lyophilised form, which comprises pharmacologically effective amount of interferon beta-1a as an active ingredient, disaccharides as a bulking agent and a non-ionic surfactant. After reconstitution, the composition can be administered intravenously.
Claims19
A pharmaceutical formulation in a lyophilised form, which comprises interferon beta-1a as an active ingredient in an amount of 2.0-15 μg in a single dosage form, disaccharides as a bulking agent, and a non-ionic surfactant.
Dependencies are inferred from the claim text.